Abstract
BackgroundCDKN2A-p16-Leiden mutation carriers have a high lifetime risk of developing pancreatic ductal adenocarcinoma (PDAC), with very poor survival......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
